§ Federal grant opportunity · RFA-OH-25-003
Occupational Safety and Health Training Project Grants (T03)
Centers for Disease Control and Prevention - ERA is accepting applications for Occupational Safety and Health Training Project Grants (T03). The deadline is October 26, 2028 and the published award range is $50K – $550K.
Key facts
- Funder
- Centers for Disease Control and Prevention - ERA
- Application deadline
- October 26, 2028
- Award range
- $50K – $550K
- Eligibility
- Foreign Organizations are not eligible to apply.
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-OH-25-003
Program overview
The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Training Project Grants (TPGs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the TPGs are one of the principal means for meeting this mandate. The majority of TPGs are in academic institutions that provide high quality undergraduate, graduate, and post graduate academic training in a variety of occupational safety and health (OSH) and allied disciplines. NIOSH also funds a limited number of non-academic TPGs to provide specialized training for target audiences and build or strengthen the Nation's OSH workforce capacity.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Centers for Disease Control and Prevention - ERA.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 26, 2028, allowing time for registration and validation.
Related grant opportunities
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.